Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 23, Number 10—October 2017

Dispatch

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015

Takaaki Tanaka, Tomohiro OishiComments to Author , Ippei Miyata, Shoko Wakabayashi, Mina Kono, Sahoko Ono, Atsushi Kato, Yoko Fukuda, Aki Saito, Eisuke Kondo, Hideto Teranishi, Yuhei Tanaka, Tokio Wakabayashi, Hiroto Akaike, Satoko Ogita, Naoki Ohno, Takashi Nakano, Kihei Terada, and Kazunobu Ouchi
Author affiliations: Kawasaki Medical School, Okayama, Japan

Main Article

Table 1

Mycoplasma pneumoniae infections diagnosed by real-time PCR and prevalence of macrolide-resistant M. pneumoniae, by district, Japan

District
Average age, y (range)
No. patients (M:F)
Macrolide resistance, % (no. positive/total no. patients)*
2008–2010
2011–2012
2013–2015
Total
Kyushu 6.4 (0–14) 239 (1.2:1) 64.1 (82/128) 27.9 (31/111) 47.3 (113/239)
Chugoku-Shikoku 7.3 (0–15) 623 (1.4:1) 68.6 (59/86) 70.6 (339/480) 80.7 (46/57) 71.3 (444/623)
Kinki 7.1 (1–15) 227 (1:1) 33.3 (7/21) 86.1 (162/188) 66.7 (12/18) 79.7 (181/227)
Kanto-Chubu 7.5 (0–13) 268 (1.1:1) 80.1 (197/246) 72.7 (16/22) 79.5 (213/268)
Hokkaido-Tohoku
7.7 (0–13)
91 (1.2:1)
84.2 (32/38)
68.1 (32/47)
16.7 (1/6)
71.4 (65/91)
Total 7.3 (0–15) 1,448 (1.3:1) 67.6 (98/145) 74.6 (812/1,089) 49.5 (106/214) 70.2 (1,016/1,448)

*2008–2010, prepandemic; 2011–2012, pandemic; 2013–2015, post pandemic.

Main Article

No table matches the in-text citation "Table 1". Please supply the missing table or delete the citation.

TOP